• / Free eNewsletters & Magazine
  • / My Account
Home>WeissLaw LLP Investigates the Synageva Biopharma Corp. Acquisition

WeissLaw LLP Investigates the Synageva Biopharma Corp. Acquisition

3party Content

Wed, 6 May 2015

NEW YORK, May 6, 2015 /PRNewswire/ -- The fairness of the proposed acquisition of Synageva Biopharma Corp. ("GEVA" or the "Company") by Alexion Pharmaceuticals, Inc. ("Alexion") is being investigated by WeissLaw LLP, a national class action, shareholder rights law firm, for possible breaches of
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.